| Followers | 842 |
| Posts | 122790 |
| Boards Moderated | 10 |
| Alias Born | 09/05/2002 |
Wednesday, August 17, 2011 5:40:48 PM
[Updated for SEC filings through 8/17/11.]
The table entries below include both ordinary and restricted
shares and both vested and non-vested options.
*10b5-1 selling plan in effect.
Shares Options
Officers
*Craig Wheeler (CEO) 531,797 752,000
*G Venkataraman (SVP/R&D) 387,001 182,820
*John Bishop (SVP/Pharma) 98,321 125,343
*Richard Shea (CFO) 91,346 272,378
*Bruce Leicher (Gen Cnsl) 90,965 160,228
*James Roach (CMO) 70,581 228,428
Directors
John Clarke 77,123 143,750
Bruce Downey 0 62,750
Marsha Fanucci 0 143,750
Peter Hutt 67,863 148,750
Thomas Koestler 0 30,000
*Bennett Shapiro 7,000 142,950
*Elizabeth Stoner 6,700 79,450
James Sulat 7,000 70,750
======================== ========= =========
All thirteen insiders 1,435,697 2,543,347
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
FEATURED Cannabix Technologies Announces Commercial Launch of Marijuana Breath Test (MBT) • Mar 16, 2026 8:37 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
